Last reviewed · How we verify
epinastine 0.1%
At a glance
| Generic name | epinastine 0.1% |
|---|---|
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis (PHASE2)
- A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (PHASE2)
- Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan (PHASE4)
- Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |